VSIR and neoplasm: High co-expression of VISTA with MHCII was also observed on both myeloid TAM populations, which suggests to us that tumor-infiltrating myeloid cells in MB have heightened antigen presentation capabilities consistent with an activated macrophage phenotype but do so in the context of a novel inhibitory immune checkpoint molecule, VISTA.